196 related articles for article (PubMed ID: 37190803)
1. Mechanism-based Pharmacological Management of Chemotherapy-induced Neuropathic Pain from Preclinical Studies to Clinical Prospective: Platinum-based Drugs, Taxanes, and Vinca Alkaloids.
Zafari N; Velayati M; Maftooh M; Khazaei M; Nassiri M; Hassanian SM; Ghayour-Mobarhan M; Ferns GA; Avan A
Curr Pharm Des; 2023; 29(16):1245-1265. PubMed ID: 37190803
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoids: Current and Future Options to Treat Chronic and Chemotherapy-Induced Neuropathic Pain.
Blanton HL; Brelsfoard J; DeTurk N; Pruitt K; Narasimhan M; Morgan DJ; Guindon J
Drugs; 2019 Jun; 79(9):969-995. PubMed ID: 31127530
[TBL] [Abstract][Full Text] [Related]
3. Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy.
Fumagalli G; Monza L; Cavaletti G; Rigolio R; Meregalli C
Front Immunol; 2020; 11():626687. PubMed ID: 33613570
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy-induced peripheral neuropathy-part 2: focus on the prevention of oxaliplatin-induced neurotoxicity.
Sałat K
Pharmacol Rep; 2020 Jun; 72(3):508-527. PubMed ID: 32347537
[TBL] [Abstract][Full Text] [Related]
5. Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview.
Chan A; Hertz DL; Morales M; Adams EJ; Gordon S; Tan CJ; Staff NP; Kamath J; Oh J; Shinde S; Pon D; Dixit N; D'Olimpio J; Dumitrescu C; Gobbo M; Kober K; Mayo S; Pang L; Subbiah I; Beutler AS; Peters KB; Loprinzi C; Lustberg MB
Support Care Cancer; 2019 Oct; 27(10):3729-3737. PubMed ID: 31363906
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-induced peripheral neuropathy: part 1-current state of knowledge and perspectives for pharmacotherapy.
Sałat K
Pharmacol Rep; 2020 Jun; 72(3):486-507. PubMed ID: 32394362
[TBL] [Abstract][Full Text] [Related]
7. Current use of drugs affecting the central nervous system for chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review.
Chu SH; Lee YJ; Lee ES; Geng Y; Wang XS; Cleeland CS
Support Care Cancer; 2015 Feb; 23(2):513-24. PubMed ID: 25256375
[TBL] [Abstract][Full Text] [Related]
8. Targeting translation: A review of preclinical animal models in the development of treatments for chemotherapy-induced peripheral neuropathy.
White D; Abdulla M; Park SB; Goldstein D; Moalem-Taylor G; Lees JG
J Peripher Nerv Syst; 2023 Jun; 28(2):179-190. PubMed ID: 36995049
[TBL] [Abstract][Full Text] [Related]
9. Neuropathic Pain and Nerve Growth Factor in Chemotherapy-Induced Peripheral Neuropathy: Prospective Clinical-Pathological Study.
Velasco R; Navarro X; Gil-Gil M; Herrando-Grabulosa M; Calls A; Bruna J
J Pain Symptom Manage; 2017 Dec; 54(6):815-825. PubMed ID: 28797868
[TBL] [Abstract][Full Text] [Related]
10. An overview of ongoing clinical trials assessing pharmacological therapeutic strategies to manage chemotherapy-induced peripheral neuropathy, based on preclinical studies in rodent models.
Bouchenaki H; Danigo A; Sturtz F; Hajj R; Magy L; Demiot C
Fundam Clin Pharmacol; 2021 Jun; 35(3):506-523. PubMed ID: 33107619
[TBL] [Abstract][Full Text] [Related]
11. Risk-reduction and treatment of chemotherapy-induced peripheral neuropathy.
Bakogeorgos M; Georgoulias V
Expert Rev Anticancer Ther; 2017 Nov; 17(11):1045-1060. PubMed ID: 28868935
[TBL] [Abstract][Full Text] [Related]
12. Role of Mitochondrial Mechanism in Chemotherapy-Induced Peripheral Neuropathy.
Waseem M; Kaushik P; Tabassum H; Parvez S
Curr Drug Metab; 2018; 19(1):47-54. PubMed ID: 29219049
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Patients Receiving 4-6 Cycles of Platinum-Based and Taxane-Based Chemotherapy: A Prospective, Single-Center Study from Kosovo.
Myftiu B; Hundozi Z; Sermaxhaj F; Blyta A; Shala N; Jashari F; Qorraj Bytyqi H; Hyseni E; Kurtishi I
Med Sci Monit; 2022 Aug; 28():e937856. PubMed ID: 36042691
[TBL] [Abstract][Full Text] [Related]
14. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.
Amara S
Ann Pharmacother; 2008 Oct; 42(10):1481-5. PubMed ID: 18698011
[TBL] [Abstract][Full Text] [Related]
15. [Peripheral neuropathy as a side effect of chemotherapy and targeted therapy].
Gießen-Jung C; von Baumgarten L
Dtsch Med Wochenschr; 2018 Jul; 113(13):970-978. PubMed ID: 29972842
[TBL] [Abstract][Full Text] [Related]
16. Prevention of chemotherapy-induced peripheral neuropathy: A review of recent findings.
Ibrahim EY; Ehrlich BE
Crit Rev Oncol Hematol; 2020 Jan; 145():102831. PubMed ID: 31783290
[TBL] [Abstract][Full Text] [Related]
17. Chemokine Signaling in Chemotherapy-Induced Neuropathic Pain.
Brandolini L; d'Angelo M; Antonosante A; Allegretti M; Cimini A
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31197114
[TBL] [Abstract][Full Text] [Related]
18. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.
Kleckner IR; Kamen C; Gewandter JS; Mohile NA; Heckler CE; Culakova E; Fung C; Janelsins MC; Asare M; Lin PJ; Reddy PS; Giguere J; Berenberg J; Kesler SR; Mustian KM
Support Care Cancer; 2018 Apr; 26(4):1019-1028. PubMed ID: 29243164
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy-induced peripheral neuropathy and rehabilitation: A review.
Zhang S
Semin Oncol; 2021 Jun; 48(3):193-207. PubMed ID: 34607709
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy-induced peripheral neuropathy: a review and implications for oncology nursing practice.
Wickham R
Clin J Oncol Nurs; 2007 Jun; 11(3):361-76. PubMed ID: 17623621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]